Previous Page  54 / 129 Next Page
Information
Show Menu
Previous Page 54 / 129 Next Page
Page Background

Mechanobiology of Disease

Poster Abstracts

49

16-POS

Board 16

Energy Landscape of RGD Motif and Syndecan-1 Binding to Human Bladder Cells of

Different Grades Studied by Dynamic Force Spectroscopy

Joanna Danilkiewicz

, Joanna Pabijan, Malgorzata Lekka.

Institute of Nuclear Physics, PAS, Kraków, Lesser, Poland.

Multiple receptors present on cell membrane mediate various interactions with extracellular

matrix (ECM). Many processes occurring in metastasis such as cell adhesion, migration,

attachment to basal matrix, and invasion involve proteins containing the RGD motif such as

fibronectin or vitronectin [1]. Thus, many cellular processes (like cell differentiation, adhesion,

migration, proliferation or survival) depend on the ECM properties. The main family of cell

surface receptors responsible for the cell–ECM interaction are integrins [2]. They bind to ECM

proteins mainly through RGD motif. However, in such proteins as fibronectin, another cell

attachment sites i.e. heparin binding sites are present to be specifically recognized by syndecan

family acting as integrin co-receptors [3].

In our studies, the unbinding properties were quantified for integrins and syndecans, assuming

that they change during the metastasis progression. An AFM-based dynamic force spectroscopy

(DFS) was used to carry out measurements of the interactions between the cell surface and the

AFM probes functionalized with either the RGD motif or monoclonal antibody against

syndecan-1. Human bladder cells originated from non-malignant epithelial cells of ureter

(HCV29) and from transitional cell carcinoma (HT1376). Obtained loading rate dependences

enabled to re-construct the energy landscapes according to the Bell-Evans model used to

characterize the unbinding properties of studied interactions.

References:

[1] Plow et al. J. Biol.Chem. 275, 21785-21788 (2000).

[2] Carey Biochem. J. 327, 1–16 (1997).

[3] Harisi et al. Onco Targets Ther.8, 1387-1398 (2015).

[4] The studies has been financed by the NCN project no UMO-2014/15/B/ST4/04737.